Empire Dermatology, one of Central New York’s largest dermatology groups, issued a statement on Friday that it will withdraw from the Excellus BlueCross BlueShield network effective Jan. 15, 2027. The decision follows the insurer’s refusal to reverse a reimbursement policy that reduces payment by 25% for lower‑value services when a physician performs both an office evaluation and a medically necessary procedure in the same visit.
Why the network exit matters for families
Dr. Brian Raphael, founder and managing partner of Empire Dermatology, explained that the new terms threaten the financial sustainability of independent medical practices. “This is not the outcome we wanted, and it is certainly not the outcome our patients deserve,” he said. “Excellus has made it clear that it does not place the same value on the access we provide to this community. Unfortunately, the current terms of our agreement with Excellus are no longer sustainable.”
For the roughly 40,000 Excellus members who receive skin‑cancer screenings, preventive care, and treatment at Empire’s offices, the change could mean higher out‑of‑pocket costs or the need to seek care elsewhere. About 3,500 of those patients are covered under Medicare Advantage plans, a group that often relies on stable provider networks to keep costs predictable.
What patients can expect after Jan. 15
Empire Dermatology said it will continue to see Excellus patients after the exit date, but the terms of coverage will change. Patients should anticipate revised co‑pays, deductibles, or the possibility of needing to submit claims for reimbursement rather than paying a fixed in‑network rate.
Patients are encouraged to contact the practice’s billing department to understand how the shift will affect their individual plans. The office will also provide guidance on alternative insurance options and assist with any necessary paperwork.
Broader implications for independent practices
The dispute highlights a growing tension between large insurers and independent medical providers across the nation. When insurers impose lower reimbursement rates, many smaller practices argue that they cannot maintain the level of care and access their communities expect. This case underscores the importance of fair valuation of medical services, especially for preventive and early‑detection care that can reduce long‑term health costs.
Local business leaders and health‑care advocates have expressed concern that such reimbursement policies could drive more independent clinics out of networks, limiting patient choice and potentially increasing travel distances for essential care.
Next steps for the community
Residents of Syracuse and the surrounding counties should monitor communications from both Empire Dermatology and Excellus for updates on billing procedures and any assistance programs that may be offered. The practice plans to hold a town‑hall style Q&A session in early February to address patient questions and discuss the impact on community health.
While the exit marks a significant shift in the local health‑care landscape, Empire Dermatology remains committed to providing high‑quality dermatologic care to all patients, regardless of insurance status. The practice’s leadership hopes that continued dialogue with insurers will eventually lead to reimbursement structures that support both provider sustainability and patient affordability.
Original reporting: CNY Central WSTM (Sinclair) – local — read the source article.